Yahyaei Azar, Mashhadi Meighani Esmat, Ghaffari Firouzeh
Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran.
Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, Iran. Emails:
Int J Fertil Steril. 2025 Jan 5;19(1):1-9. doi: 10.22074/ijfs.2024.2015631.1570.
The fertility preservation (FP) is a paramount concern for oncology patients and should be regarded as an essential component of their overall cancer management strategy. The magnitude of this issue has been recognized in FP guidelines. The formulation and execution of harmonized guidelines and policies concerning the provision of FP services, inclusive of therapeutic strategies and standardization of procedures, are crucial to surmount disagreements regarding the delivery of these therapeutic services and avert delays in cancer treatment. The matter of FP and the methodology for managing the treatment and follow-up of cancer patients should be documented as a component of their management guideline, thereby providing patients with clear recommendations on fertility preservation. In this manuscript, we provide a succinct overview of existing international guidelines history and reference comprehensive networks of FP services for oncology patients. Furthermore, we present the Royan Institute's guideline specifically designed for preserving the fertility of female oncology patients.
生育力保存(FP)是肿瘤患者极为关注的问题,应被视为其整体癌症管理策略的重要组成部分。这一问题的重要性已在生育力保存指南中得到认可。制定和执行关于提供生育力保存服务的统一指南和政策,包括治疗策略和程序标准化,对于克服在提供这些治疗服务方面的分歧以及避免癌症治疗延误至关重要。生育力保存问题以及癌症患者治疗和随访的管理方法应记录在其管理指南中,从而为患者提供关于生育力保存的明确建议。在本手稿中,我们简要概述了现有国际指南的历史,并参考了针对肿瘤患者的生育力保存服务综合网络。此外,我们还介绍了专门为保存女性肿瘤患者生育力而设计的罗扬研究所指南。